FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

243411000001103: Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1849541000001111 Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1849551000001114 Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Is a Product containing precisely oxybutynin hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has active ingredient Oxybutynin hydrochloride false Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 4 x 21 tablets Is pack of False Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Is pack of False Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) 84 tablet 4 x 21 tablets Has AMP True Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) 56 tablet 2 x 28 tablets Has AMP True Oxybutynin 5mg tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start